Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G17DT in Stage I-III Gastric Cancer (GC3)
NCT02233712Phase 2Completed
- Sponsor
- Cancer Advances, Inc.
- Start
- Aug 1999
- Primary completion
- Mar 2000
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of G17DT immunogen in gastric cancer (GC), sponsored by Cancer Advances, Inc.. Started Aug 1999; status: completed.
02
Drugs
G17DT immunogen
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02233712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02233712.